CRIS Current Research Information System

GUIDI, SANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.176
AS - Asia 2.060
EU - Europa 2.037
AF - Africa 257
SA - Sud America 116
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.147
SG - Singapore 744
CN - Cina 629
IT - Italia 628
GB - Regno Unito 404
DE - Germania 294
VN - Vietnam 288
HK - Hong Kong 183
SE - Svezia 168
NL - Olanda 96
IN - India 91
TG - Togo 84
BR - Brasile 82
CI - Costa d'Avorio 82
RU - Federazione Russa 73
FR - Francia 69
IE - Irlanda 64
UA - Ucraina 60
KR - Corea 41
SC - Seychelles 37
ZA - Sudafrica 36
CH - Svizzera 35
BG - Bulgaria 34
JO - Giordania 28
FI - Finlandia 25
EE - Estonia 24
BE - Belgio 22
JP - Giappone 21
CA - Canada 19
AR - Argentina 15
NG - Nigeria 12
AT - Austria 11
MX - Messico 9
EC - Ecuador 8
PL - Polonia 8
GR - Grecia 7
ID - Indonesia 7
IR - Iran 7
CL - Cile 5
LT - Lituania 5
TR - Turchia 5
BD - Bangladesh 4
ES - Italia 4
AU - Australia 3
PY - Paraguay 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
IQ - Iraq 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HR - Croazia 1
JM - Giamaica 1
PK - Pakistan 1
RE - Reunion 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.651
Salva come PNG Salva come JPEG
Città #
Singapore 487
Southend 352
Fairfield 348
Chandler 338
Ashburn 308
Bologna 243
Santa Clara 212
Hong Kong 182
Houston 166
Seattle 159
Wilmington 158
Woodbridge 143
Ann Arbor 136
Hefei 123
Cambridge 118
Beijing 100
Princeton 92
Lomé 84
Abidjan 82
Dong Ket 78
Boardman 70
Hanoi 65
Dublin 64
Ho Chi Minh City 62
Frankfurt am Main 50
Falls Church 42
Los Angeles 42
Seoul 41
Turin 41
Redmond 35
Sofia 34
Westminster 34
Jacksonville 33
Dallas 32
Bern 30
Nanjing 30
Milan 29
Padova 29
Amman 28
Buffalo 27
San Diego 26
Munich 25
Berlin 22
Brussels 21
Shenyang 20
Rimini 18
Tokyo 17
Jinan 16
New York 16
Hebei 15
Helsinki 14
Redondo Beach 14
The Dalles 14
Tianjin 14
Shanghai 13
Abeokuta 12
Rome 12
Bengaluru 11
Florence 11
Guangzhou 11
Redwood City 11
Saint Petersburg 11
Trento 11
Amsterdam 10
Castel Maggiore 10
Changsha 10
Toronto 10
Zhengzhou 10
Nanchang 9
Bolzano 8
Chicago 8
Dearborn 8
Des Moines 8
Meldola 8
Taizhou 8
Wuhan 8
Bắc Ninh 7
Ha Long 7
London 7
Monmouth Junction 7
Mülheim 7
Phoenix 7
São Paulo 7
Udine 7
Vienna 7
Haikou 6
Hải Dương 6
Lappeenranta 6
Olalla 6
Bremen 5
Brooklyn 5
Da Nang 5
Düsseldorf 5
Falkenstein 5
Forlì 5
Jakarta 5
Montreal 5
Naples 5
Norwalk 5
Orem 5
Totale 5.339
Salva come PNG Salva come JPEG
Nome #
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 278
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 258
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 210
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 202
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 196
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 196
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 193
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 191
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 188
Postnatal neurogenesis in the dentate gyrus of the guinea pig 186
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 181
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 178
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 175
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 170
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 169
Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea pig before puberty 168
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 164
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 161
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 154
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 152
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 152
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 151
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 149
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 146
Sex differences in the hilar mossy cells of the guinea-pig before puberty. 144
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 144
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 142
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 140
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 138
Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with Down syndrome. 138
Timing of therapies for downsyndrome: The sooner, the better 137
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 136
null 130
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 130
Is it possible to improve neurodevelopmental abnormalities in Down syndrome? 129
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 129
Postnatal neurogenesis in the hippocampal dentate gyrus and subventricular zone of the Goettingen minipig. 124
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 117
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 117
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model 116
Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome 110
Targeting APP/AICD in Down syndrome 109
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome 103
null 100
Dendritic phenotype and proliferation potency in the hippocampal dentate gyrus of the Ts66Yah model of Down syndrome 97
null 97
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 93
Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down sindrome 90
Neurogenesis impairment: An early developmental defect in Down syndrome 85
null 83
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 77
Fisiologia gastrointestinale 74
Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty 62
Effects of early environment on pyramidal neuron morphology in field CA1 of the guinea-pig 37
Sex differences in the hilar mossy cells of the guinea-pig before puberty 36
Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide 28
“Administration of the BDNF mimetic 7,8-Dihydroxyflavone during adolescence rescues neuron maturation and improves hippocampus- dependent memory in the Ts65Dn mouse model of Down syndrome”. 19
“Il trattamento adolescenziale con il BDNF mimetico 7,8-diidrossiflavone influenza la metilazione del DNA nell'ippocampo del modello Ts65Dn di sindrome di Down” 12
“Early pharmacotherapies for the rescue of intellectual disability in Down syndrome” 12
“Adolescence represents an important window of opportunity for the rescue of dendritic pathology with a BDNF mimetic in a mouse model of Down syndrome” 11
“Trattamento adolescenziale con il BDNF mimetico 7,8- diidrossiflavone: una strategia utile per migliorare lo sviluppo della fascia dentata ippocampica nel modello Ts65Dn di sindrome di Down”. 6
“La somministrazione neonatale di astaxantina tramite nanoparticelle ha un effetto proproliferativo nel modello murino Ts65Dn” 6
“Is it possible to prevent or counteract Alzheimer’s disease in Down syndrome with molecules with antioxidant and anti-inflammatory properties?” 6
“Neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles fosters hippocampal neurogenesis in a mouse model of Down syndrome” 5
“Analisi dell’espressione genica in ippocampi di topi Ts65Dn sottoposti a trattamento adolescenziale con il BDNF-mimetico 7,8 diidrossiflavone” 5
“Trattamento neonatale con astaxantina veicolata tramite nanoparticelle: effetti sullo sviluppo ippocampale e sullo stress ossidativo nel modello murino Ts65D” 5
“Effects of 7,8-dihydroxyflavone treatment on DNA methylation profiles of adolescent Ts65Dn mice hippocampus” 4
“Effects of neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles on hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome” 4
“Il trattamento con il polifenolo Polidatina migliora lo sviluppo cerebrale e la memoria ippocampo-dipendente nel topo Ts65Dn, modello di sindrome di Down” 3
Totale 7.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021415 0 0 0 0 0 35 13 55 74 58 33 147
2021/2022847 49 40 50 38 95 54 64 51 37 53 164 152
2022/20231.231 107 232 65 169 70 99 44 59 187 12 91 96
2023/2024343 23 62 19 40 22 68 3 8 4 25 40 29
2024/20251.479 94 112 107 119 269 74 128 71 28 120 91 266
2025/20261.665 322 261 246 292 417 127 0 0 0 0 0 0
Totale 7.858